Bepotastine Besilate
10 NDCs across 4 manufacturers|8 Generic,2 Brand
Bepotastine Besilate is used to treat allergic conjunctivitis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Sep 8, 2009, and the first generic was approved Mar 5, 2019. In 2024, Medicare Part D spent $11 million on Bepotastine Besilate across 63,000 claims for 18,000 beneficiaries.
Bepotastine Besilate is available as 10 NDCs from 4 manufacturers (8 generic, 2 brand), with NADAC prices from $8.36 to $55.94 per ML — the most expensive product costs about 6.7× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
10
8G / 2B
Manufacturers
4
competing in market
Price Spread
$8.36 – $55.94
per ML
7d Activity
avg -0.4% WoW · of 10 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
4 manufacturers producing BEPOTASTINE BESILATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
BEPREVE 1.5% EYE DROPS | $55.9357 per ML | — |
BEPREVE 1.5% EYE DROPS | $53.8111 per ML | — |
BEPOTASTINE 1.5% EYE DROP | $11.2533 per ML | -1.26% |
BEPOTASTINE 1.5% EYE DROP | $11.2533 per ML | -1.26% |
BEPOTASTINE 1.5% EYE DROP | $11.2533 per ML | -1.26% |
BEPOTASTINE 1.5% EYE DROP | $11.2533 per ML | -1.26% |
BEPOTASTINE 1.5% EYE DROP | $8.3591 per ML | +0.54% |
BEPOTASTINE 1.5% EYE DROP | $8.3591 per ML | +0.54% |
BEPOTASTINE 1.5% EYE DROP | $8.3591 per ML | +0.54% |
BEPOTASTINE 1.5% EYE DROP | $8.3591 per ML | +0.54% |
Frequently Asked Questions
What is Bepotastine Besilate used to treat?
Bepotastine Besilate is used to treat allergic conjunctivitis, per the National Library of Medicine's MED-RT classification.
When did Bepotastine Besilate become available as a generic?
FDA approved the first generic Bepotastine Besilate (ANDA) on Mar 5, 2019.
How much does Medicare spend on Bepotastine Besilate?
In 2024, Medicare Part D spent $11 million on Bepotastine Besilate across 63,000 claims for 18,000 beneficiaries.
How many Bepotastine Besilate products are on the market?
The Bepotastine Besilate drug market contains 10 NDCs from 4 manufacturers — 8 generic and 2 brand products.
What is the price range for Bepotastine Besilate?
NADAC reference prices for Bepotastine Besilate range from $8.3591 to $55.9357 per ML — the most expensive product costs about 6.7× the cheapest.
Is generic Bepotastine Besilate cheaper than brand?
The average generic NADAC for Bepotastine Besilate is $9.8062 per ML, versus $54.8734 for brand-labeled products — brand versions average about 5.6× the generic price.
Which manufacturers make Bepotastine Besilate?
4 manufacturers list Bepotastine Besilate in NADAC. Ranked by number of NDCs, the largest are Bausch & Lomb Incorporated (4), Somerset Therapeutics, LLC (2), Mylan Pharmaceuticals Inc. (2), Bausch & Lomb Americas Inc. (2).
How has the price of Bepotastine Besilate changed recently?
Over the past 7 days, 4 Bepotastine Besilate NDCs rose and 4 fell, with a market-wide average change of -0.4%.